Suppr超能文献

心作为血管加压素和其他心血管肽在健康和心血管疾病中的靶标。

The Heart as a Target of Vasopressin and Other Cardiovascular Peptides in Health and Cardiovascular Diseases.

机构信息

Department of Experimental and Clinical Physiology, Laboratory of Center for Preclinical Research, The Medical University of Warsaw, Banacha 1B, 02-097 Warsaw, Poland.

出版信息

Int J Mol Sci. 2022 Nov 20;23(22):14414. doi: 10.3390/ijms232214414.

Abstract

The automatism of cardiac pacemaker cells, which is tuned, is regulated by the autonomic nervous system (ANS) and multiple endocrine and paracrine factors, including cardiovascular peptides. The cardiovascular peptides (CPs) form a group of essential paracrine factors affecting the function of the heart and vessels. They may also be produced in other organs and penetrate to the heart via systemic circulation. The present review draws attention to the role of vasopressin (AVP) and some other cardiovascular peptides (angiotensins, oxytocin, cytokines) in the regulation of the cardiovascular system in health and cardiovascular diseases, especially in post-infarct heart failure, hypertension and cerebrovascular strokes. Vasopressin is synthesized mostly by the neuroendocrine cells of the hypothalamus. There is also evidence that it may be produced in the heart and lungs. The secretion of AVP and other CPs is markedly influenced by changes in blood volume and pressure, as well as by other disturbances, frequently occurring in cardiovascular diseases (hypoxia, pain, stress, inflammation). Myocardial infarction, hypertension and cardiovascular shock are associated with an increased secretion of AVP and altered responsiveness of the cardiovascular system to its action. The majority of experimental studies show that the administration of vasopressin during ventricular fibrillation and cardiac arrest improves resuscitation, however, the clinical studies do not present consisting results. Vasopressin cooperates with the autonomic nervous system (ANS), angiotensins, oxytocin and cytokines in the regulation of the cardiovascular system and its interaction with these regulators is altered during heart failure and hypertension. It is likely that the differences in interactions of AVP with ANS and other CPs have a significant impact on the responsiveness of the cardiovascular system to vasopressin in specific cardiovascular disorders.

摘要

心脏起搏器细胞的自动调节是由自主神经系统 (ANS) 和多种内分泌和旁分泌因素调节的,包括心血管肽。心血管肽 (CPs) 形成一组重要的旁分泌因子,影响心脏和血管的功能。它们也可能在其他器官中产生,并通过全身循环渗透到心脏。本综述提请注意血管加压素 (AVP) 和其他一些心血管肽 (血管紧张素、催产素、细胞因子) 在调节心血管系统在健康和心血管疾病中的作用,特别是在心肌梗死后心力衰竭、高血压和脑血管中风中。血管加压素主要由下丘脑的神经内分泌细胞合成。也有证据表明,它可能在心脏和肺部产生。AVP 和其他 CPs 的分泌明显受到血容量和压力变化以及心血管疾病中经常发生的其他干扰的影响(缺氧、疼痛、应激、炎症)。心肌梗死、高血压和心血管休克与 AVP 分泌增加和心血管系统对其作用的反应性改变有关。大多数实验研究表明,在心室颤动和心脏骤停期间给予血管加压素可改善复苏,但临床研究并未提供一致的结果。血管加压素与自主神经系统 (ANS)、血管紧张素、催产素和细胞因子合作调节心血管系统,其与这些调节剂的相互作用在心力衰竭和高血压期间发生改变。很可能 AVP 与 ANS 和其他 CPs 的相互作用的差异对特定心血管疾病中心血管系统对血管加压素的反应性有重大影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验